RT Journal Article
SR Electronic
T1 National statutory reporting: not even ticking the boxes? The quality of ‘Learning from Deaths’ reporting in Quality Accounts within the NHS in England 2017-2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.12.22277525
DO 10.1101/2022.07.12.22277525
A1 Brummell, Z
A1 Braun, D
A1 Hussein, Z
A1 Moonesinghe, SR
A1 Vindrola-Padros, C
YR 2022
UL http://medrxiv.org/content/early/2022/07/12/2022.07.12.22277525.abstract
AB Introduction Regulation through statutory reporting is used in healthcare internationally to improve accountability, quality of care and patient safety. Since 2017 within the National Health Service (NHS) in England NHS Secondary Care Trusts (NSCTs) are legally required to report annually both quantitative and qualitative information related to patient deaths within their care within their publicly available Quality Accounts as part of a countrywide patient safety programme: The Learning from Deaths (LfDs) programme.Method All LfDs reports published between 2017 (programme inception) and 2020 were reviewed and evaluated through a critical realist lens, quantitatively reported using descriptive statistics and qualitatively using reflexive thematic analysis.Results In 2017/18 44% of NSCTs reported all six statutory elements of the LfDs reporting regulations, in 2019/20 35% of NSCTs were reporting this information. A small number of NSCTs did not report any parts of the LfDs regulatory requirements between 2017 and 2020. Multiple qualitative themes arose from this study suggesting problematic engagement with the LfDs programme, erroneous reporting accuracy and written communication.Conclusions The LfDs programme has to some extent reduced variation and improved consistency to the way that NSCTs identify, report and investigate deaths. However, three years into the LfDs programme the majority of NSCTs are not reporting as required by law. This makes the validity of National statutory reporting in Quality accounts within the NHS in England questionable as a regulatory process.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe PPI work in this study was funded by NIHR UCLH Biomedical Research Centre (BRC617/PPI/ZB/104990)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All data used is publicly available from NHS Secondary Care Trust websites in EnglandI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available from NHS Secondary Care Trust websites in England